870P POPPY: A Phase II Trial to Assess the Efficacy and Safety Profile of Pembrolizumab in Patients of Performance Status 2 with Recurrent/metastatic Squamous Cell Carcinoma of the Head and Neck (R/M HNSCC)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要